News and analysis on medical technology

Stryker Agrees to Acquire ZuriMED, Maker of FiberLocker Rotator Cuff Augmentation System

Terms were not disclosed for the deal, which Stryker says will strengthen its shoulder portfolio across sports medicine and arthroplasty.

By News DeskSeptember 1, 20262 min read
A Stryker World Headquarters sign on a lawn in front of a two-storey office building
The sign outside Stryker's world headquarters on Airview Boulevard, photographed in 2012. Vraal48, CC BY-SA 4.0, via Wikimedia Commons · CC BY-SA 4.0

Key points

  • Stryker signed a definitive agreement to acquire privately held ZuriMED, developer of the FiberLocker System; terms were not disclosed.
  • FiberLocker attaches a polyester patch over a rotator cuff repair to support it; the FDA cleared it through the 510(k) pathway in December 2024.
  • The deal is subject to customary closing conditions, and the companies will run separately until it closes.

Stryker has signed a definitive agreement to acquire ZuriMED, a privately held company that developed the FiberLocker System for rotator cuff augmentation, Stryker said on August 31. The companies did not disclose financial terms, MedTech Dive reported.

The transaction is subject to customary closing conditions, and Stryker and ZuriMED will continue to operate as separate entities until it closes, according to Stryker's announcement. Stryker did not give an expected closing date.

The FiberLocker System

Rotator cuff augmentation is a procedure in which a patch is applied to a torn rotator cuff to support healing and prevent the tissue from tearing again, MedTech Dive explained. With FiberLocker, a polyester patch is applied during or after rotator cuff tendon repair and attached to the surrounding tissue. The implant is intended to stay in place, supporting the sutures and bone anchors from the surgery.

The FDA found the FiberLocker System substantially equivalent to a legally marketed device under the 510(k) pathway on December 11, 2024, according to the agency's database. The entry lists ZuriMED Technologies AG as the applicant, names the implant as the SpeedPatch PET, and classifies the device as non-absorbable surgical mesh for orthopedic reinforcement of tendon.

Stryker said the commercialized technology offers a novel approach to rotator cuff augmentation with increased biomechanical strength, meant to address a key clinical failure mode in rotator cuff repair. MedTech Dive noted that estimated re-tear rates after rotator cuff repair range from 11% to 94%, with higher rates for older patients.

Shoulder strategy

Stryker called rotator cuff augmentation one of the fastest-growing areas in sports medicine and a significant opportunity within shoulder care, citing a Mordor Intelligence market report. It said the acquisition will enhance its ability to support shoulder specialists across both sports medicine and arthroplasty, strengthening its portfolio in rotator cuff augmentation.

"ZuriMED has developed a differentiated technology that addresses an important clinical need within shoulder care," said Andy Pierce, Stryker's group president of MedSurg and Neurotechnology. "We are excited about the opportunity to add the FiberLocker System to Stryker's portfolio."

ZuriMED is based in Zurich, Switzerland, according to MedTech Dive. Stryker's announcement is datelined Portage, Michigan.

Sources

  1. Stryker signs definitive agreement to acquire ZuriMED to enhance its shoulder offering, Stryker, August 31, 2026
  2. Stryker to add rotator cuff repair tech with ZuriMED buy, MedTech Dive, September 1, 2026
  3. 510(k) Premarket Notification K241219: FiberLocker System, U.S. Food and Drug Administration, December 11, 2024